Selma Ugurel

27PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Feb 20, 2026
Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma.

Georg Lodde, Jonida Dollani, Wolfgang Galetzka

|Oct 25, 2025
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss.

Hannah Zillikens, Corinna Scheib, Vicky Peller

|Sep 24, 2025
Tertiary lymphoid structures in Merkel cell carcinoma facilitate naïve and central memory T-cell infiltration linked to immunotherapy response.

Nalini Srinivas, Ivelina Spassova, Kuan Cheok Lei

|Jun 03, 2025
Long-Term Follow-Up of Real-World Adjuvant Anti-PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma.

Georg C Lodde, Jessica C Hassel, Imke von Wasielewski

|Dec 31, 2024
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma.

Jan-Malte Placke, Jenny Bottek, Renata Váraljai

Pageof 5